{
    "response": "**Overall Treatment Decision:** Yes\u2014initiate\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** High-dose intravenous methylprednisolone 1 g daily for 3\u20135 days\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Acute inflammatory myelitis suspected Early steroids improve recovery Start immediately after urgent MRI excludes compressive/infective lesion\n\n*   **Treatment:** Proton pump inhibitor\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Gastric protection during high-dose corticosteroids\n\n*   **Treatment:** Venous thromboembolism prophylaxis (LMWH and compression stockings)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Reduced mobility Prevention of DVT/PE\n\n*   **Treatment:** Physiotherapy and gait rehabilitation\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Improve mobility and balance Prevent deconditioning and falls\n\n*   **Treatment:** Plasma exchange (5\u20137 sessions)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Use if inadequate response to steroids within days Particularly effective in NMOSD or severe relapse\n\n*   **Treatment:** Disease-modifying therapy for multiple sclerosis (e.g., ocrelizumab/high-efficacy agent)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Initiate after diagnostic confirmation and counselling Requires infection screening and vaccinations\n\n*   **Treatment:** Rituximab-based therapy for AQP4-positive NMOSD\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Only if AQP4-IgG positive/NMOSD confirmed Start after acute attack management\n\n*   **Treatment:** Urgent neurosurgical decompression\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Only indicated if MRI shows compressive thoracic cord lesion Not appropriate for inflammatory demyelination\n\n\ntreatments = [{\"treatment\": \"High-dose intravenous methylprednisolone 1 g daily for 3\\u20135 days\", \"timing\": \"Start Now\", \"reasons\": [\"Acute inflammatory myelitis suspected\", \"Early steroids improve recovery\", \"Start immediately after urgent MRI excludes compressive/infective lesion\"]}, {\"treatment\": \"Proton pump inhibitor\", \"timing\": \"Start Now\", \"reasons\": [\"Gastric protection during high-dose corticosteroids\"]}, {\"treatment\": \"Venous thromboembolism prophylaxis (LMWH and compression stockings)\", \"timing\": \"Start Now\", \"reasons\": [\"Reduced mobility\", \"Prevention of DVT/PE\"]}, {\"treatment\": \"Physiotherapy and gait rehabilitation\", \"timing\": \"Start Now\", \"reasons\": [\"Improve mobility and balance\", \"Prevent deconditioning and falls\"]}, {\"treatment\": \"Plasma exchange (5\\u20137 sessions)\", \"timing\": \"Delay\", \"reasons\": [\"Use if inadequate response to steroids within days\", \"Particularly effective in NMOSD or severe relapse\"]}, {\"treatment\": \"Disease-modifying therapy for multiple sclerosis (e.g., ocrelizumab/high-efficacy agent)\", \"timing\": \"Delay\", \"reasons\": [\"Initiate after diagnostic confirmation and counselling\", \"Requires infection screening and vaccinations\"]}, {\"treatment\": \"Rituximab-based therapy for AQP4-positive NMOSD\", \"timing\": \"Delay\", \"reasons\": [\"Only if AQP4-IgG positive/NMOSD confirmed\", \"Start after acute attack management\"]}, {\"treatment\": \"Urgent neurosurgical decompression\", \"timing\": \"Delay\", \"reasons\": [\"Only indicated if MRI shows compressive thoracic cord lesion\", \"Not appropriate for inflammatory demyelination\"]}]"
}